These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8390865)

  • 1. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
    Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.
    Tiebout RF; Sauerwein RW; van der Meer WG; van Boxtel-Oosterhof F; Zeijlemaker WP
    Immunology; 1987 Feb; 60(2):187-93. PubMed ID: 3028938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
    Steinitz M; Koskimies S; Klein G; Mäkelä O
    J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
    Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
    Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C; Zubler RH
    J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD; Stewart JP; Arrand JR; Mackett M
    Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic and natural factors promoting production of murine and human monoclonal antibodies.
    Astaldi Ricotti GC; Negri C; Cerino A; Bestagno M; Fussi F
    Ann Ist Super Sanita; 1991; 27(1):155-60. PubMed ID: 1958025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density-dependent responsiveness to autocrine growth factors of Epstein-Barr virus transformed human B lymphocytes.
    Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M
    Microbiologica; 1992 Jul; 15(3):303-7. PubMed ID: 1501588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
    Stein LD; Ledgley CJ; Sigal NH
    J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G; Blaese RM; Yarchoan R
    J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
    Yajima M; Kanda T; Takada K
    J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
    Blazar BA; Sutton LM; Strome M
    Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
    Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
    Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.